DRUG

anlotinib

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for anlotinib

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
CD73 poor prognosis 0.208 Mid reproduces known none

Clinical trials

200 registered trials for anlotinib

Source: ClinicalTrials.gov

← All drugs